Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Fluticasone

Client Email

Product

Fluticasone
Fluticasone Furoate
CAS 89365-50-4
U.S. EXCLUSIVITIES

PharmaCompass Sponsored Ads

Contact Supplier

Vamsi labs Fluticasone Propionate

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Fluticasone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 30 USDMF, 31 CEP/COS, 6 JDMF, 7 EU WC, 1 KDMF, 25 NDC API, 44 Listed Suppliers, $ API Reference Price

69 API Suppliers
30 USDMF
31 CEP/COS
6 JDMF
7 EU WC
1 KDMF
25 NDC API
44 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

46 Drugs in Development

46 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

429 FDF Dossiers, 70 FDA Orange Book, 212 Europe, 32 Canada, 13 Australia, 51 South Africa, 51 Listed Dossiers

429 FDF Dossiers
70 FDA Orange Book
212 Europe
32 Canada
13 Australia
51 South Africa
51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY, SPRAY, METERED;NASAL - 0.05MG/SPRAY, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.25MG/INH, POWDER;INHALATION - 0.03MG/INH, POWDER;INHALATION - 0.055MG/INH, POWDER;INHALATION - 0.113MG/INH, POWDER;INHALATION - 0.232MG/INH, POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH, LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.044MG/INH, AEROSOL, METERED;INHALATION - 0.11MG/INH, AEROSOL, METERED;INHALATION - 0.22MG/INH

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY
SPRAY, METERED;NASAL - 0.05MG/SPRAY
POWDER;INHALATION - 0.05MG/INH
POWDER;INHALATION - 0.1MG/INH
POWDER;INHALATION - 0.25MG/INH
POWDER;INHALATION - 0.03MG/INH
POWDER;INHALATION - 0.055MG/INH
POWDER;INHALATION - 0.113MG/INH
POWDER;INHALATION - 0.232MG/INH
POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH
POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH
POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH
LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH
AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH
AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH
AEROSOL, METERED;INHALATION - 0.044MG/INH
AEROSOL, METERED;INHALATION - 0.11MG/INH
AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 1 DKSH, 2 Jai Radhe Sales, 9 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 10 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 5 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 20 Kerry, 1 Kima Chemical, 10 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 10 Roquette, 8 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

1 Rochem International Inc
2 SPI Pharma
1 DKSH
2 Jai Radhe Sales
9 Gangwal Healthcare
7 Nanjing Well Pharmaceutical
10 Actylis
3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
11 BASF
5 DFE Pharma
2 Finar
7 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
20 Kerry
1 Kima Chemical
10 Microlex e.U
1 Nanjing Bold Chemical
1 Pharmatrans-Sanaq
4 Pluviaendo
2 Prachin Chemical
10 Roquette
8 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
1 The Dow Chemical Company
1 Valens Pharmachem
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders, 23 Direct Compression, 21 Solubilizers, 20 Thickeners and Stabilizers, 18 Topical, 15 Disintegrants & Superdisintegrants, 14 Co-Processed Excipients, 13 Parenteral, 12 Granulation, 10 Emulsifying Agents, 10 Controlled & Modified Release, 7 Film Formers & Plasticizers, 6 Surfactant & Foaming Agents, 6 Rheology Modifiers, 6 Coating Systems & Additives, 3 Taste Masking, 2 Chewable & Orodispersible Aids, 2 Lubricants & Glidants, 1 API Stability Enhancers

40 Fillers, Diluents & Binders
23 Direct Compression
21 Solubilizers
20 Thickeners and Stabilizers
18 Topical
15 Disintegrants & Superdisintegrants
14 Co-Processed Excipients
13 Parenteral
12 Granulation
10 Emulsifying Agents
10 Controlled & Modified Release
7 Film Formers & Plasticizers
6 Surfactant & Foaming Agents
6 Rheology Modifiers
6 Coating Systems & Additives
3 Taste Masking
2 Chewable & Orodispersible Aids
2 Lubricants & Glidants
1 API Stability Enhancers

DIGITAL CONTENT

10 DATA COMPILATION #PharmaFlow, 142 NEWS #PharmaBuzz

10 DATA COMPILATION #PharmaFlow
142 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 164 Finished Drug Prices, 12 Annual Reports

4 US Medicaid Prescriptions
164 Finished Drug Prices
12 Annual Reports

MARKET PLACE

15 APIs, 4 FDF Dossiers, 1 EXCIPIENTS

15 APIs
4 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

572 US Patents, 11 US Exclusivities, 53 Health Canada Patents

572 US Patents
11 US Exclusivities
53 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 7 USP, 9 Others

4 EDQM
7 USP
9 Others

$ API Ref.Price (USD/KG) : 19,251 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

11 All

01 1OPTINOSE US INC

02 10TEVA PHARM

filter Product Reset all filters

11 All

01 7FLUTICASONE PROPIONATE

02 4FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

filter Exclusivity Expiration Date Reset all filters

11 All

01 52024-07-09

02 52025-01-09

03 12027-03-15

filter Exclusivity Code Reset all filters

11 All

01 1I-940

02 2M-61

03 2NPP

04 1NS

05 5PED

EUROAPI Fluticasone

US Patents
US Exclusivities
Health Canada Patents

Product Main Page

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2025-01-09

Application Number

208798

Product Number

7

Exclusivity Details

01

TEVA PHARM

FLUTICASONE PROPIONATE

Formnext Forum

Not Confirmed

TEVA PHARM

Israel

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2025-01-09

Application Number : 208798

Product Number : 7

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2024-07-09

Application Number

208798

Product Number

4

Exclusivity Details

02

TEVA PHARM

FLUTICASONE PROPIONATE

Formnext Forum

Not Confirmed

TEVA PHARM

Israel

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2024-07-09

Application Number : 208798

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NS

Exclusivity Expiration Date

2024-07-09

Application Number

208798

Product Number

7

Exclusivity Details

03

TEVA PHARM

FLUTICASONE PROPIONATE

Formnext Forum

Not Confirmed

TEVA PHARM

Israel

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : NS

Exclusivity Expiration Date : 2024-07-09

Application Number : 208798

Product Number : 7

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2024-07-09

Application Number

208798

Product Number

1

Exclusivity Details

04

TEVA PHARM

FLUTICASONE PROPIONATE

Formnext Forum

Not Confirmed

TEVA PHARM

Israel

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2024-07-09

Application Number : 208798

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-61

Exclusivity Expiration Date

2024-07-09

Application Number

208799

Product Number

4

Exclusivity Details

05

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Formnext Forum

Not Confirmed

TEVA PHARM

Israel

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : M-61

Exclusivity Expiration Date : 2024-07-09

Application Number : 208799

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OPTINOSE US INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-940

Exclusivity Expiration Date

2027-03-15

Application Number

209022

Product Number

1

Exclusivity Details

06

OPTINOSE US INC

FLUTICASONE PROPIONATE

Formnext Forum

Not Confirmed

OPTINOSE US INC

U.S.A

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : I-940

Exclusivity Expiration Date : 2027-03-15

Application Number : 209022

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-61

Exclusivity Expiration Date

2024-07-09

Application Number

208799

Product Number

1

Exclusivity Details

07

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Formnext Forum

Not Confirmed

TEVA PHARM

Israel

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : M-61

Exclusivity Expiration Date : 2024-07-09

Application Number : 208799

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2025-01-09

Application Number

208799

Product Number

4

Exclusivity Details

08

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Formnext Forum

Not Confirmed

TEVA PHARM

Israel

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2025-01-09

Application Number : 208799

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2025-01-09

Application Number

208798

Product Number

4

Exclusivity Details

09

TEVA PHARM

FLUTICASONE PROPIONATE

Formnext Forum

Not Confirmed

TEVA PHARM

Israel

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2025-01-09

Application Number : 208798

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2025-01-09

Application Number

208799

Product Number

1

Exclusivity Details

10

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Formnext Forum

Not Confirmed

TEVA PHARM

Israel

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2025-01-09

Application Number : 208799

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?